Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastoma
about
Sui generis: gene therapy and delivery systems for the treatment of glioblastomaMarmosets as a preclinical model for testing "off-label" use of doxycycline to turn on Flt3L expression from high-capacity adenovirus vectors.Adenoviral vector-mediated gene therapy for gliomas: coming of age.DDMC-p53 gene therapy with or without cisplatin and microwave ablation.An Engineered Endomorphin-2 Gene for Morphine Withdrawal SyndromeProtection effect of survivin protein overexpression on acute myocardial infarction in rats.Development of gene therapy for blood disorders: an update.Preclinical safety evaluation of recombinant adeno-associated virus 2 vector encoding human tumor necrosis factor receptor-immunoglobulin Fc fusion geneGlioma virus therapies between bench and bedside.Effectiveness and preclinical safety profile of doxycycline to be used "off-label" to induce therapeutic transgene expression in a phase I clinical trial for gliomaClinical trials of viral therapy for malignant gliomas.Intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with 2-diethylaminoethyl-dextran methyl methacrylate copolymer non-viral vector-p53.Monitoring adenoviral based gene delivery in rat glioma by molecular imaging.Feasibility of Applying Helper-Dependent Adenoviral Vectors for Cancer Immunotherapy.
P2860
Q26850467-292D9C3A-2B80-48E4-BF1B-94279764AB04Q33950709-C53F7989-8FE7-40FF-88A9-B969F4ABEC85Q34022048-277B146C-4DC6-4D04-92E5-FC4F252D694BQ35654976-BA085CCB-512A-49C9-AC56-91FE52907F9AQ35966106-F29EC6E0-3BC0-4EB3-A679-8498A0AC52E9Q36182887-658FB6E1-E257-41C9-B879-8A6FD1FA611EQ37132611-A9C2A385-1C23-4200-916D-FADC6A0CCFBDQ37134964-D7F4321D-10AB-4F17-BED7-9B96DFF3F6D0Q37580510-4B97001B-1DB7-4470-ACA3-4564F6535FDEQ37730116-EE8E992C-5EB1-4841-81B8-13E029C87595Q38153777-56B8E6AD-9E7F-4B31-9BC7-F3E4D80B227DQ38451785-BC5BC9C6-C604-46A2-A711-B185DE20758CQ40585840-B33D1F86-B8AE-4FE0-9AFC-BD12ACE64EEEQ51847569-134FCFBE-866E-4CA0-8BFC-D4FE549C6D66
P2860
Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastoma
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Safety profile, efficacy, and ...... linical trial for glioblastoma
@ast
Safety profile, efficacy, and ...... linical trial for glioblastoma
@en
type
label
Safety profile, efficacy, and ...... linical trial for glioblastoma
@ast
Safety profile, efficacy, and ...... linical trial for glioblastoma
@en
prefLabel
Safety profile, efficacy, and ...... linical trial for glioblastoma
@ast
Safety profile, efficacy, and ...... linical trial for glioblastoma
@en
P2093
P2860
P921
P1476
Safety profile, efficacy, and ...... linical trial for glioblastoma
@en
P2093
Alireza Salem
Ashley Appelhans
Catherine Farrokhi
Christopher Paran
Chunyan Liu
Donna Palmer
Ghulam Muhammad A K M
Johnny Krasinkiewicz
Kurt M Kroeger
Kyle R Kelson
P2860
P304
P356
10.1016/J.TAAP.2013.02.001
P577
2013-02-09T00:00:00Z